Why does null hypothesis testing matter for split luciferase assays?

Null hypothesis testing ensures that observed luminescence reflects true protein-protein interactions rather than background or non-specific effects, supporting rigorous target validation and reducing false positives in discovery workflows.

How does independent variable isolation fit the split luciferase workflow?

Isolating variables such as plasmid combinations and transfection conditions allows teams to attribute luminescence changes specifically to protein interactions, strengthening mechanistic conclusions and supporting confident decision-making.

What do quantitative luminescence measurements enable in this assay?

Quantitative luminescence provides a direct, scalable readout of interaction strength, enabling statistical comparison across conditions and supporting prioritization of targets or interaction partners in early discovery.

Why are replication requirements critical for cross-functional collaboration?

Replication across wells and experimental runs ensures assay reproducibility, enabling reliable data sharing and interpretation between discovery, screening, and translational teams.

Which statistical analysis capabilities are required before assay implementation?

Teams must establish protocols for background correction, signal normalization, and statistical significance testing to ensure that luminescence outputs are robust and actionable for R&D decision-making.

Split Luciferase Complementation Assay to Identify Specific Protein-Protein Interactions

JoVE Encyclopedia of Experiments

Biological Techniques

0 views • 4:02 min • July 8th, 2025

$$\rightleftharpoonup{xx}$$ $$\longleftharp{xx}$$, $$\longrightharp{xx}$$,

Protein-protein interactions are crucial for vital cellular functions.

To study the interactions between transmembrane proteins — membrane proteins that span the lipid bilayer of the cell membrane, begin with the wells of a multi-well plate containing an adherent mammalian cell culture.

Next, add a solution containing a suitable transfection agent and a pair of expression plasmids.

One of the expression plasmids encodes a transmembrane protein of interest fused to the small non-functional fragment of the luciferase enzyme; the other plasmid encodes a second transmembrane protein of interest fused to the large non-functional fragment of the luciferase enzyme.

Incubate the plate. The transfection agent facilitates the cellular uptake of the expression plasmids.

Successfully transfected cells express the transmembrane proteins. The interaction between the expressed transmembrane proteins brings the small and large fragments facing the cytoplasm into close proximity, causing them to bind and form the active luciferase enzyme.

Replace the media in the wells with serum-free media to minimize background luminescence. Add furimazine — a cell-permeable luciferase substrate — solution. Furimazine enters the cells, following which luciferase oxidizes the furimazine, generating high-intensity luminescence.

Using a microplate reader, measure the luminescence, which is suggestive of the strong interaction between the transmembrane proteins.

Harvest the adherent HEK293T cell culture by trypsinization, and re-suspend the cells in a dedicated complete growth medium. Plate the cells onto a clear bottom, white side, 96-well plate. Adjust the total number of wells to accommodate all tested combinations and controls, including replicates. Then, culture the cells overnight in standard conditions.

On the next day, transfect the cells with the desired combinations of expression plasmids. Dilute the plasmids in a serum-free medium to 6.25 nanograms per microliter for each construct, and add the lipid-based transfection reagent at an appropriate lipid-to-DNA ratio.

Incubate the plasmids according to manufacturer's instruction. Then, add 8 microliters of the lipid-DNA mixture to the designated wells. Mix the content of the plate with gentle rotation, and culture the cells for 20 to 24 hours in standard conditions.

On the next day, replace the conditioned medium in each well with 100 microliters of a serum-free medium, making sure that the cells do not detach upon medium exchange.

Related Videos

0 Views

Last updated: 11 July 2026

Split Luciferase Complementation Assay to Identify Specific Protein-Protein Interactions

Overview

Key Study Components

Area of Science

Background

Purpose of Study

Methods Used

Main Results

Conclusions

Frequently Asked Questions

Executive Industry Relevance

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

Screening & Assay Development

Translational & Preclinical Research

Pipeline & Workflow Integration

Operational & Enterprise Impact

Implementation Considerations

Biopharma FAQs

Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b

Construction of CRISPR Plasmids and Detection of Knockout Efficiency in Mammalian Cells through a Dual Luciferase Reporter System

Native Cell Membrane Nanoparticles System for Membrane Protein-Protein Interaction Analysis

Bimolecular Complementation Affinity Purification to Isolate Two Interacting Proteins

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Investigating Protein-protein Interactions in Live Cells Using Bioluminescence Resonance Energy Transfer

Identification of Protein Interaction Partners in Mammalian Cells Using SILAC-immunoprecipitation Quantitative Proteomics

Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay (PCA) in Living Cells

Luciferase Complementation Imaging Assay in Nicotiana benthamiana Leaves for Transiently Determining Protein-protein Interaction Dynamics

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification (BiCAP)